Holding(s) in Company
Mark H Dixon and Diana Dixon, through Rock Nominees Limited, have acquired a major holding in SkinBioTherapeutics plc, now holding 20.470% of the voting rights, which equates to 53,000,000 shares. This notification follows an acquisition of voting rights on February 10, 2026, and the issuer was informed on February 11, 2026. The individuals are not controlled by any other entity and do not control any other undertakings holding interests in the issuer.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Mark H Dixon and Diana Dixon |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
| Name | Rock Nominees Limited |
| City and country of registered office (if applicable) | London, UK |
| 5. Date on which the threshold was crossed or reached vi : | 10/02/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 11/02/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 20.470% | 20.470% | 53,000,000 |
| Position of previous notification (if applicable) | n/a | n/a | n/a |
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| Ordinary shares GB00BF33H870 | 53,000,000 | 20.470% | |
| SUBTOTAL 8. A | 53,000,000 | 20.470% | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
| Name of the proxy holder | N/A |
| The number and % of voting rights held | N/A |
| The date until which the voting rights will be held | N/A |
| 11. Additional information xvi | |
| Place of completion | London |
| Date of completion | 12 February 2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.